Saxenda

Description

Saxenda is an injectable medical treatment indicated for weight loss and weight maintenance in adults with obesity, or overweight associated with health problems. Its active ingredient, liraglutide, acts as a GLP-1 peptide analogue, regulating appetite and prolonging the feeling of fullness. Unlike products that only speed up metabolism, Saxenda acts directly on the brain centers that control hunger, promoting a sustained reduction in calorie intake. It may also be prescribed for adolescents aged 12 to 17 with obesity and a body weight over 60 kg, under medical supervision.

Benefits

• Controls appetite and helps maintain the weight loss achieved.
• Supports a reduction in body mass index (BMI).
• Reduces the risk of obesity-related diseases.
• Improves blood sugar regulation and the feeling of fullness.
• Compatible with diets and physical exercise programs.

Application sites

• Subcutaneous injection in the abdomen.
• It can also be injected in the thigh or upper arm.

Main ingredients

Liraglutide: GLP-1 peptide analogue that regulates appetite, delays gastric emptying and prolongs satiety, helping to control calorie intake.

Packaging

1 prefilled 3 ml pen

Frequently asked questions

How often is Saxenda administered?
It is administered once a day by subcutaneous injection, following a gradual dose increase.

How is the dose escalated?
It starts at 0.6 mg daily and increases weekly until reaching 3 mg, according to the patient's tolerance.

Does it cause side effects?
Nausea, diarrhea or mild abdominal discomfort may occur, which usually disappear over time.

Should it be combined with diet and exercise?
Yes, Saxenda is most effective when accompanied by a balanced diet and regular physical activity.

Can it be used in adolescents?
Yes, it is approved for young people aged 12 to 17 with obesity and a body weight over 60 kg, under medical supervision.